Press Releases Qiagen N.V.

Equities

QGEN

NL0015002CX3

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2025-12-08 pm EST			5-day change	1st Jan Change
45.86 ^USD	-2.45%		-3.13%	+0.13%

Dec. 03	Qiagen N.V. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 10:50 AM
Dec. 02	Qiagen N.V. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 11:15 AM

Press Releases

Qiagen N : Citi Global Healthcare Conference Investor Introduction	Dec. 01	PU
Qiagen N : Sustainability Report (Supplier Code of Conduct 2025 2026)	Nov. 26	PU
Pryor Cashman Represents Soleus Capital In Sale Of Parse Biosciences To QIAGEN N.V. For Up To $280 Million	Nov. 13	AQ
Qiagen N : Wolfe Research Healthcare Conference 2025 Investor Introduction	Nov. 11	PU
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025	Nov. 10	BU
Qiagen N : hoc Announcement according to Art. 17 Market Abuse Regulation	Nov. 05	PU
Qiagen: Q3 Earnings Snapshot	Nov. 04	AQ
QIAGEN N.V.: QIAGEN announces CEO transition plan	Nov. 04	EQ
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase	Nov. 04	BU
QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions	Nov. 04	BU
QIAGEN N.V.: QIAGEN to return approximately $500 million to shareholders through a synthetic share repurchase	Nov. 04	EQ
QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025	Oct. 30	BU
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing	Oct. 28	BU
QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast	Oct. 13	BU
Q3 2025 Results Webcast Dial-in Details: Wednesday, November 5, 2025	Oct. 13	PU
Qiagen N : Bank of America Corporation - Qiagen N.V. - VENLO	Oct. 02	PU
Qiagen N : Halfjaarlijkse financiële verslaggeving	Sep. 30	PU
Qiagen N : Baader Conference Investor Introduction	Sep. 15	PU
QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio	Sep. 10	BU
Qiagen N : Kepler Cheuvreux Autumn Conference Investor Introduction	Sep. 05	PU
From survivor to reformer: One woman’s pursuit of justice through DNA analysis	Sep. 05	PU
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing	Sep. 02	BU
Qiagen N : Using HGMD Public? Your Data Is 3 Years Behind	Aug. 28	PU
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds	Aug. 28	BU
Qiagen N : Using trusted cancer data can accelerate drug discovery and development	Aug. 28	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Qiagen lifts adjusted EPS guidance after Q3 earnings beat and new acquisition

November 05, 2025 at 09:14 am EST